Patients and Caregivers
For additional information,
click here or contact
Medtronic Patient Services
For information and resources about the agreement with the FDA, click here or contact
Medtronic Technical Services
Medtronic Neuromodulation has entered in an agreement with the U.S. Food and Drug Administration (FDA) related to the SynchroMed drug infusion system and the Neuromodulation quality system.
Provided on this website relating to the agreement are: